Senators question Allergan CEO on tribe patent deal
Por um escritor misterioso
Descrição
A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
CQ Researcher - Prescription Drug Costs
Allergan deal with Mohawk tribe casts patent shadow
Allergan's Mohawk Tribe Patent Defense Is Eyewash - Court
Allergan plc
Allergan's Restasis to Face Impending Generic Competition After Patent License Play Fails - Xtalks
Here's How Drug Companies Game the Patent System - Bloomberg
Senators question Allergan CEO on tribe patent deal
Speaker Bios Do Not Delete - Foundry Events
Trump attacks drug companies for high prices, weighs options to curb monopolies
Allergan does patent deal for Restasis with Native American tribe
de
por adulto (o preço varia de acordo com o tamanho do grupo)
